CAC
NFYS.WS

Cowen and Company’s Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFYS.WS Stock Holding History

Cowen and Company’s Portfolio NFYS.WS Stock Details NFYS.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-249,800
Closed -$8.74K – 772
2024
Q2 		$8.74K Buy
+249,800
New +$11K ﹤0.01% 473

Other funds holding NFYS.WS

CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Cowen and Company's NFYS.WS Position: Q3 2024 in Review

Cowen and Company sold out of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) in Q3 2024, closing a stake of 249,800 shares — an estimated $8.74K sold.

Cowen and Company first reported a position in NFYS.WS in Q2 2024 and held it in 1 quarter. The position peaked at $8.74K in Q2 2024. 5 funds tracked by Wall St. Rank hold NFYS.WS as of Q3 2024.

  • Cowen and Company reported no remaining Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2024 after selling out during the quarter.
  • Cowen and Company sold 249,800 Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2024, an estimated $8.74K.
  • Cowen and Company first reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2024 and held it in 1 quarter.
  • Cowen and Company's Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $8.74K in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2024.

Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.